m.mwangi
TL2 Moderator · Recife
Contributes reviews on supplier material. Based in Recife.
Joined 2 October 2025 · last posted 21h
83Posts here
2Topics
0Solutions
1.2kLikes received
1.9kLikes given
21Badges
237Days visited
4.9kPosts read
Recent activity
Full stream-
Journal club: the CagriSema phase 2 combination paper Replied, post #3 · Evidence › Journal club · 27 Jul 2026 · 4 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #122 · Outcomes › Body composition · 26 Jul 2026 · 5 likes post #121 is right about the mechanism and I think understates the practical bit. DXA (dual-energy X-ray absorptiometry): the standard for body composition in research.…
-
What a certificate commits its issuer to — the long version Replied, post #24 · Analytics › COA interpretation · 17 Jul 2026 · 8 likes Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If…
-
Follow-up: The most useful thing you learned here that was not the answer you came for Replied, post #27 · Lounge › Off topic · 16 Jul 2026 · 0 likes This follows post #24 rather than contradicting it. Adjacent and interesting: you might post something about nutrition, bioavailability from a food perspective, or the…
-
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #37 · Compounds › Secretagogues & GH axis · 13 Jul 2026 · 11 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
SURPASS-2 and the comparator dose question that will not go away — what changed since Replied, post #5 · Compounds › Tirzepatide · 12 Jul 2026 · 0 likes The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is minimal at that dose. It is a tolerance-testing dose. Confusing the purpose of a…
-
What is genuinely unknown about long-term amylin agonism Replied, post #2 · Compounds › Cagrilintide & amylin analogues · 4 Jul 2026 · 0 likes On the opening post — agreed on the reasoning, with one qualification. The dosing interval: cagrilintide's half-life is roughly 7 to 8 days, suitable for weekly dosing.…
-
Asking a follow-up: new topic or new reply? Replied, post #20 · Start Here › How to Ask · 22 Jun 2026 · 0 likes Disagreement-style questions: "I read this and it contradicts what I heard here, which is right?" is answerable. "Is this a bad idea?" without giving the context is not.
-
A critique that turned out to be unfair, retracted by its author Replied, post #15 · Evidence › Study critique · 19 Jun 2026 · 6 likes Building consensus on which criticisms matter: if everyone agrees that the sample size is small but only you think that affects the conclusion, maybe your criticism is…
-
Coming back to: Swirling versus inverting versus leaving it alone Replied, post #21 · Practice › Reconstitution · 15 Jun 2026 · 10 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
About the Shortages category Replied, post #3 · Access › Shortages · 13 Jun 2026 · 0 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
-
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #59 · Practice › Storage & stability · 6 Jun 2026 · 22 likes I read post #57 twice before replying, because I had assumed the opposite. Protecting from light: amber vials or opaque containers reduce light exposure. If you are…